VEGFR2/CD309 anticorps (N-Term)
Aperçu rapide pour VEGFR2/CD309 anticorps (N-Term) (ABIN2792307)
Antigène
Voir toutes VEGFR2/CD309 (VEGFR2) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- N-Term
-
Fonction
- KDR Antibody - N-terminal region
-
Séquence
- LNVGIDFNWE YPSSKHQHKK LVNRDLKTQS GSEMKKFLST LTIDGVTRSD
-
Homologie
- Cow: 86%, Dog: 100%, Horse: 100%, Human: 100%, Pig: 100%
-
Attributs du produit
- This is a rabbit polyclonal antibody against KDR. It was validated on Western Blot using a cell lysate as a positive control.
-
Purification
- Affinity Purified
-
Immunogène
- The immunogen is a synthetic peptide directed towards the N terminal region of human KDR
-
-
anti-VEGF Receptor 2 (VEGFR2) (AA 1326-1356), (C-Term) antibody
VEGFR2 Reactivité: Humain WB, IF, FACS, IHC (p) Hôte: Lapin Polyclonal RB01536 unconjugated
anti-VEGF Receptor 2 (VEGFR2) (AA 20-242) antibodyVEGFR2 Reactivité: Humain WB, IHC, FACS, ICC Hôte: Lapin Polyclonal unconjugated
anti-VEGF Receptor 2 (VEGFR2) (AA 20-244) antibodyVEGFR2 Reactivité: Souris, Rat WB, IHC, IF, FACS, ICC Hôte: Lapin Polyclonal unconjugated
anti-VEGF Receptor 2 (VEGFR2) (AA 20-764) antibodyVEGFR2 Reactivité: Humain ELISA, FACS, ICC Hôte: Souris Monoclonal 4B4 unconjugated
anti-VEGF Receptor 2 (VEGFR2) (AA 1225-1356) antibodyVEGFR2 Reactivité: Humain ELISA, FACS Hôte: Souris Monoclonal 1A9A3 unconjugated
anti-VEGF Receptor 2 (VEGFR2) (AA 101-200) antibodyVEGFR2 Reactivité: Humain FACS, IHC (p), IF (p), IHC (fro) Hôte: Lapin Polyclonal unconjugated
anti-VEGF Receptor 2 (VEGFR2) (AA 1326-1356) antibodyVEGFR2 Reactivité: Humain WB, IHC, ELISA, IF, FACS Hôte: Lapin Polyclonal unconjugated
anti-VEGF Receptor 2 (VEGFR2) (pTyr996) antibodyVEGFR2 Reactivité: Humain WB, IHC (p) Hôte: Lapin Polyclonal RB2667 unconjugated
anti-VEGF Receptor 2 (VEGFR2) (AA 1150-1250) antibodyVEGFR2 Reactivité: Humain WB Hôte: Lapin Polyclonal unconjugated
anti-VEGF Receptor 2 (VEGFR2) (pTyr951) antibodyVEGFR2 Reactivité: Humain WB, IHC, ELISA, IF Hôte: Lapin Polyclonal unconjugated
-
-
Indications d'application
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.5 mg/mL
-
Buffer
- Purified antibody supplied in 1x PBS buffer with 0.09 % (w/v) sodium azide and 2 % sucrose.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Conseil sur la manipulation
- prevent freeze-thaw cycles
-
Stock
- 4 °C,-20 °C
-
Stockage commentaire
- For short term use, store at 2-8C up to 1 week. For long term storage, store at -20 °C in small aliquots to prevent freeze-thaw cycles.
-
-
- VEGFR2/CD309 (VEGFR2) (VEGF Receptor 2 (VEGFR2))
-
Autre désignation
- KDR
-
Sujet
-
Background Information: KDR is the receptor for VEGF or VEGFC. It has a tyrosine-protein kinase activity. The VEGF-kinase ligand/receptor signaling system plays a key role in vascular development and regulation of vascular permeability. In case of HIV-1 infection, the interaction with extracellular viral Tat protein seems to enhance angiogenesis in Kaposi's sarcoma lesions.
Gene Name: Kinase insert domain receptor (a type III receptor tyrosine kinase)
Alternative Symbols: FLK1, CD309, VEGFR, VEGFR2
Protein Name: Vascular endothelial growth factor receptor 2
-
Poids moléculaire
- 151kDa
-
ID gène
- 3791
-
NCBI Accession
- NP_002244
-
UniProt
- P35968
-
Pathways
- Signalisation RTK, Glycosaminoglycan Metabolic Process, Signaling Events mediated by VEGFR1 and VEGFR2, Growth Factor Binding, Regulation of long-term Neuronal Synaptic Plasticity, VEGF Signaling
Antigène
-
